Abbott Laboratories (ABT) Financial Statements (2026 and earlier)

Company Profile

Business Address 100 ABBOTT PARK ROAD
ABBOTT PARK, IL 60064-3500
State of Incorp. IL
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in millions)

12/31/2025
Q4
9/30/2025
Q3
6/30/2025
Q2
3/31/2025
Q1
12/31/2024
Q4
9/30/2024
Q3
6/30/2024
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments7,7337,2826,8447,9677,7887,219
Cash and cash equivalent7,5116,9516,5327,6167,5586,987
Short-term investments222331312351230232
Receivables8,1387,9727,3276,9257,0516,854
Inventory, net of allowances, customer advances and progress billings6,7086,9546,6396,1946,8136,814
Inventory6,7086,9546,6396,1946,8136,814
Other undisclosed current assets2,2602,2602,3432,5702,1502,232
Total current assets:24,83924,46823,15323,65623,80223,119
Noncurrent Assets
Operating lease, right-of-use asset   1,075  
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization11,50411,39510,93210,65810,62110,233
Long-term investments and receivables951958907886912877
Long-term investments951958907886912877
Intangible asset, including goodwill, after accumulated amortization29,56929,87229,62029,75531,01031,135
Goodwill23,97123,95223,35923,10823,65823,308
Intangible asset, excluding goodwill, after accumulated amortization5,5985,9206,2616,6477,3527,827
Regulated entity, other noncurrent assets   53  
Other undisclosed noncurrent assets17,31817,30616,83615,3318,0117,653
Total noncurrent assets:59,34259,53158,29557,75850,55449,898
TOTAL ASSETS:84,18183,99981,44881,41474,35673,017
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities13,23712,93212,49812,65712,74812,145
Accounts payable4,1234,3064,2144,1954,0344,125
Accrued liabilities9,1148,6268,2848,4628,7148,020
Debt1,3455075061,5002,1541,615
Total current liabilities:14,58213,43913,00414,15714,90213,760
Noncurrent Liabilities
Long-term debt and lease obligation11,59612,93012,73612,62512,82513,139
Long-term debt, excluding current maturities11,59612,93012,73612,62512,82513,139
Liabilities, other than long-term debt   6,219  
Liability, pension and other postretirement and postemployment benefits   1,880  
Other liabilities   3,443  
Operating lease, liability   896  
Other undisclosed noncurrent liabilities6,7396,8016,6445126,6016,558
Total noncurrent liabilities:18,33519,73119,38019,35619,42619,697
Total liabilities:32,91733,17032,38433,51334,32833,457
Equity
Equity, attributable to parent50,95450,56548,81147,66439,79639,318
Common stock25,41225,28425,12525,15325,02024,858
Treasury stock, value(16,877)(16,610)(16,612)(16,844)(16,476)(15,759)
Accumulated other comprehensive loss(6,684)(6,576)(7,417)(7,906)(7,804)(8,135)
Retained earnings49,10348,46747,71547,26139,05638,354
Equity, attributable to noncontrolling interest310264253237232242
Total equity:51,26450,82949,06447,90140,02839,560
TOTAL LIABILITIES AND EQUITY:84,18183,99981,44881,41474,35673,017

Income Statement (P&L) ($ in millions)

12/31/2025
Q4
9/30/2025
Q3
6/30/2025
Q2
3/31/2025
Q1
12/31/2024
Q4
9/30/2024
Q3
6/30/2024
Q2
Revenues11,36911,14210,35810,97410,63510,377
Cost of revenue
(Cost of Product and Service Sold)
(5,075)(4,854)(4,468)(4,942)(4,698)(4,603)
Gross profit:6,2946,2885,8906,0325,9375,774
Operating expenses(4,237)(4,236)(4,197)(4,121)(4,078)(4,105)
Operating income:2,0572,0521,6931,9111,8591,669
Nonoperating income24421921625522378
Investment income, nonoperating777182919182
Other nonoperating income (expense)150137127154121(10)
Interest and debt expense(121)(121)(131)(136)(142)(140)
Income from continuing operations before income taxes:2,1802,1501,7782,0301,9401,607
Income tax expense (benefit)(536)(371)(453)7,199(294)(305)
Net income attributable to parent:1,6441,7791,3259,2291,6461,302
Other undisclosed net income (loss) available to common stockholders, basic(44)21(25)(34)(6)(5)
Net income available to common stockholders, diluted:1,6001,8001,3009,1951,6401,297

Comprehensive Income ($ in millions)

12/31/2025
Q4
9/30/2025
Q3
6/30/2025
Q2
3/31/2025
Q1
12/31/2024
Q4
9/30/2024
Q3
6/30/2024
Q2
Net income:1,6441,7791,3259,2291,6461,302
Other comprehensive income (loss)(2)43817363(27)
Comprehensive income:1,6421,8221,3339,4021,7091,275
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(106)798481(275)26858
Comprehensive income, net of tax, attributable to parent:1,5362,6201,8149,1271,9771,333

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: